42 reports of this reaction
2.4% of all METHYL SALICYLATE reports
#5 most reported adverse reaction
DYSPEPSIA is the #5 most commonly reported adverse reaction for METHYL SALICYLATE, manufactured by Mission Pharmacal Company. There are 42 FDA adverse event reports linking METHYL SALICYLATE to DYSPEPSIA. This represents approximately 2.4% of all 1,767 adverse event reports for this drug.
Patients taking METHYL SALICYLATE who experience dyspepsia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPEPSIA is a less commonly reported adverse event for METHYL SALICYLATE, but still significant enough to appear in the safety profile.
In addition to dyspepsia, the following adverse reactions have been reported for METHYL SALICYLATE:
The following drugs have also been linked to dyspepsia in FDA adverse event reports:
DYSPEPSIA has been reported as an adverse event in 42 FDA reports for METHYL SALICYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPEPSIA accounts for approximately 2.4% of all adverse event reports for METHYL SALICYLATE, making it a notable side effect.
If you experience dyspepsia while taking METHYL SALICYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.